Small Pharma Inc. (TSXV: DMT / OTCQB: DMTTF), a biotechnology company focused on short-duration psychedelic-assisted therapies for mental health conditions,...
Despite no revenue yet, the company expects to have enough cash to fund the 2024 fiscal year. The post Small Pharma Posts C$23 Million Loss for...
Small Pharma Reports Financial Results for the Fiscal Year Ended February 28, 2023 and Recent Business Highlights The post Small Pharma Reports 2023 Financial...
With clinical trials moving MDMA toward FDA approval, celebrities continuing to share their psychedelic experiences, and politicians supporting new research...
Local initiatives and cultural changes are playing a pivotal role in spearheading decriminalization and legalization efforts and the future of legal psychedelics. The...
The U.S. Food and Drug Administration (FDA) has released a groundbreaking draft guidance to provide crucial insights for researchers exploring The post...
With clinical trials moving MDMA toward FDA approval, celebrities continuing to share their psychedelic experiences, and politicians supporting new research...
Psychedelic Science 2023 wrapped up with lessons from drug policy activism, psychedelics and sex, wisdom from elders, and protestors speaking out against...
Psychedelic Science 2023 wrapped up with lessons from drug policy activism, psychedelics and sex, wisdom from elders, and protestors speaking out against...
image: MPH Photos/Shutterstock The best-known story of psychedelic use among professional athletes is the time in 1970 when the San Diego Padres’s Doc...